104 related articles for article (PubMed ID: 15624758)
1. Prognosis-related molecular markers in pediatric central nervous system tumors.
Rickert CH
J Neuropathol Exp Neurol; 2004 Dec; 63(12):1211-24. PubMed ID: 15624758
[TBL] [Abstract][Full Text] [Related]
2. Prognosis-related histomorphological and immunohistochemical markers in central nervous system tumors of childhood and adolescence.
Rickert CH; Paulus W
Acta Neuropathol; 2005 Jan; 109(1):69-92. PubMed ID: 15647946
[TBL] [Abstract][Full Text] [Related]
3. Comparative genomic hybridization in central and peripheral nervous system tumors of childhood and adolescence.
Rickert CH; Paulus W
J Neuropathol Exp Neurol; 2004 May; 63(5):399-417. PubMed ID: 15198120
[TBL] [Abstract][Full Text] [Related]
4. Genetic expression profiles of adult and pediatric ependymomas: molecular pathways, prognostic indicators, and therapeutic targets.
Nagasawa DT; Trang A; Choy W; Spasic M; Yew A; Zarinkhou G; Garcia HM; Yang I
Clin Neurol Neurosurg; 2013 Apr; 115(4):388-99. PubMed ID: 23374238
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.
Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C
Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150
[TBL] [Abstract][Full Text] [Related]
6. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms.
Braoudaki M; Lambrou GI; Giannikou K; Milionis V; Stefanaki K; Birks DK; Prodromou N; Kolialexi A; Kattamis A; Spiliopoulou CA; Tzortzatou-Stathopoulou F; Kanavakis E
J Hematol Oncol; 2014 Dec; 7():96. PubMed ID: 25551588
[TBL] [Abstract][Full Text] [Related]
7. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
8. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
[No Abstract] [Full Text] [Related]
9. Pediatric ependymomas: will molecular biology change patient management?
Grill J; Bergthold G; Ferreira C
Curr Opin Oncol; 2011 Nov; 23(6):638-42. PubMed ID: 21892086
[TBL] [Abstract][Full Text] [Related]
10. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci.
Pfister S; Remke M; Benner A; Mendrzyk F; Toedt G; Felsberg J; Wittmann A; Devens F; Gerber NU; Joos S; Kulozik A; Reifenberger G; Rutkowski S; Wiestler OD; Radlwimmer B; Scheurlen W; Lichter P; Korshunov A
J Clin Oncol; 2009 Apr; 27(10):1627-36. PubMed ID: 19255330
[TBL] [Abstract][Full Text] [Related]
11. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC
J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123
[TBL] [Abstract][Full Text] [Related]
12. Current and emerging biomarkers in tumors of the central nervous system: Possible diagnostic, prognostic and therapeutic applications.
Khan IN; Ullah N; Hussein D; Saini KS
Semin Cancer Biol; 2018 Oct; 52(Pt 1):85-102. PubMed ID: 28774835
[TBL] [Abstract][Full Text] [Related]
13. hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors.
Fan X; Wang Y; Kratz J; Brat DJ; Robitaille Y; Moghrabi A; Perlman EJ; Dang CV; Burger PC; Eberhart CG
Am J Pathol; 2003 Jun; 162(6):1763-9. PubMed ID: 12759234
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic molecular markers in common adult gliomas.
Rivera AL; Pelloski CE
Expert Rev Mol Diagn; 2010 Jul; 10(5):637-49. PubMed ID: 20629512
[TBL] [Abstract][Full Text] [Related]
15. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
[TBL] [Abstract][Full Text] [Related]
16. Molecular abnormalities in pediatric embryonal brain tumors--analysis of loss of heterozygosity on chromosomes 1, 5, 9, 10, 11, 16, 17 and 22.
Zakrzewska M; Rieske P; Debiec-Rychter M; Zakrzewski K; Polis L; Fiks T; Liberski PP
Clin Neuropathol; 2004; 23(5):209-17. PubMed ID: 15581023
[TBL] [Abstract][Full Text] [Related]
17. Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization.
Tong CY; Hui AB; Yin XL; Pang JC; Zhu XL; Poon WS; Ng HK
J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):187-93. PubMed ID: 14758948
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implication of p27 expression in primary central nervous system lymphoma.
Kunishio K; Nagao S
Brain Tumor Pathol; 2006 Oct; 23(2):77-81. PubMed ID: 18095123
[TBL] [Abstract][Full Text] [Related]
19. Applications of Genomic Sequencing in Pediatric CNS Tumors.
Bavle AA; Lin FY; Parsons DW
Oncology (Williston Park); 2016 May; 30(5):411-23. PubMed ID: 27188671
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of childhood germ cell tumors with comparative genomic hybridization.
Schneider DT; Schuster AE; Fritsch MK; Calaminus G; Harms D; Göbel U; Perlman EJ
Klin Padiatr; 2001; 213(4):204-11. PubMed ID: 11528555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]